A Single Glycan at the 99-Loop of Human Kallikrein-related Peptidase 2 Regulates Activation and Enzymatic Activity

Human kallikrein-related peptidase 2 (KLK2) is a key serine protease in semen liquefaction and prostate cancer together with KLK3/prostate-specific antigen. In order to decipher the function of its potential N-glycosylation site, we produced pro-KLK2 in Leishmania tarentolae cells and compared it wi...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of biological chemistry Vol. 291; no. 2; pp. 593 - 604
Main Authors: Guo, Shihui, Skala, Wolfgang, Magdolen, Viktor, Briza, Peter, Biniossek, Martin L, Schilling, Oliver, Kellermann, Josef, Brandstetter, Hans, Goettig, Peter
Format: Journal Article
Language:English
Published: United States 08.01.2016
Subjects:
ISSN:1083-351X
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Human kallikrein-related peptidase 2 (KLK2) is a key serine protease in semen liquefaction and prostate cancer together with KLK3/prostate-specific antigen. In order to decipher the function of its potential N-glycosylation site, we produced pro-KLK2 in Leishmania tarentolae cells and compared it with its non-glycosylated counterpart from Escherichia coli expression. Mass spectrometry revealed that Asn-95 carries a core glycan, consisting of two GlcNAc and three hexoses. Autocatalytic activation was retarded in glyco-pro-KLK2, whereas the activated glyco-form exhibited an increased proteolytic resistance. The specificity patterns obtained by the PICS (proteomic identification of protease cleavage sites) method are similar for both KLK2 variants, with a major preference for P1-Arg. However, glycosylation changes the enzymatic activity of KLK2 in a drastically substrate-dependent manner. Although glyco-KLK2 has a considerably lower catalytic efficiency than glycan-free KLK2 toward peptidic substrates with P2-Phe, the situation was reverted toward protein substrates, such as glyco-pro-KLK2 itself. These findings can be rationalized by the glycan-carrying 99-loop that prefers to cover the active site like a lid. By contrast, the non-glycosylated 99-loop seems to favor a wide open conformation, which mostly increases the apparent affinity for the substrates (i.e. by a reduction of Km). Also, the cleavage pattern and kinetics in autolytic inactivation of both KLK2 variants can be explained by a shift of the target sites due to the presence of the glycan. These striking effects of glycosylation pave the way to a deeper understanding of kallikrein-related peptidase biology and pathology.
AbstractList Human kallikrein-related peptidase 2 (KLK2) is a key serine protease in semen liquefaction and prostate cancer together with KLK3/prostate-specific antigen. In order to decipher the function of its potential N-glycosylation site, we produced pro-KLK2 in Leishmania tarentolae cells and compared it with its non-glycosylated counterpart from Escherichia coli expression. Mass spectrometry revealed that Asn-95 carries a core glycan, consisting of two GlcNAc and three hexoses. Autocatalytic activation was retarded in glyco-pro-KLK2, whereas the activated glyco-form exhibited an increased proteolytic resistance. The specificity patterns obtained by the PICS (proteomic identification of protease cleavage sites) method are similar for both KLK2 variants, with a major preference for P1-Arg. However, glycosylation changes the enzymatic activity of KLK2 in a drastically substrate-dependent manner. Although glyco-KLK2 has a considerably lower catalytic efficiency than glycan-free KLK2 toward peptidic substrates with P2-Phe, the situation was reverted toward protein substrates, such as glyco-pro-KLK2 itself. These findings can be rationalized by the glycan-carrying 99-loop that prefers to cover the active site like a lid. By contrast, the non-glycosylated 99-loop seems to favor a wide open conformation, which mostly increases the apparent affinity for the substrates (i.e. by a reduction of Km). Also, the cleavage pattern and kinetics in autolytic inactivation of both KLK2 variants can be explained by a shift of the target sites due to the presence of the glycan. These striking effects of glycosylation pave the way to a deeper understanding of kallikrein-related peptidase biology and pathology.
Author Kellermann, Josef
Skala, Wolfgang
Brandstetter, Hans
Biniossek, Martin L
Magdolen, Viktor
Schilling, Oliver
Goettig, Peter
Briza, Peter
Guo, Shihui
Author_xml – sequence: 1
  givenname: Shihui
  surname: Guo
  fullname: Guo, Shihui
  organization: From the Department of Molecular Biology, University of Salzburg, 5020 Salzburg, Austria
– sequence: 2
  givenname: Wolfgang
  surname: Skala
  fullname: Skala, Wolfgang
  organization: From the Department of Molecular Biology, University of Salzburg, 5020 Salzburg, Austria
– sequence: 3
  givenname: Viktor
  surname: Magdolen
  fullname: Magdolen, Viktor
  organization: the Klinische Forschergruppe der Frauenklinik, Klinikum Rechts der Isar der TU München, 81675 Munich, Germany
– sequence: 4
  givenname: Peter
  surname: Briza
  fullname: Briza, Peter
  organization: From the Department of Molecular Biology, University of Salzburg, 5020 Salzburg, Austria
– sequence: 5
  givenname: Martin L
  surname: Biniossek
  fullname: Biniossek, Martin L
  organization: the Institute of Molecular Medicine and Cell Research and
– sequence: 6
  givenname: Oliver
  surname: Schilling
  fullname: Schilling, Oliver
  organization: the Institute of Molecular Medicine and Cell Research and BIOSS Centre for Biological Signaling Studies, University of Freiburg, 79104 Freiburg, Germany, the German Cancer Consortium (DKTK), 69120 Heidelberg, Germany, the German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany, and
– sequence: 7
  givenname: Josef
  surname: Kellermann
  fullname: Kellermann, Josef
  organization: the Max-Planck-Institute for Biochemistry, 82152 Martinsried, Germany
– sequence: 8
  givenname: Hans
  surname: Brandstetter
  fullname: Brandstetter, Hans
  organization: From the Department of Molecular Biology, University of Salzburg, 5020 Salzburg, Austria
– sequence: 9
  givenname: Peter
  surname: Goettig
  fullname: Goettig, Peter
  email: peter.goettig@sbg.ac.at
  organization: From the Department of Molecular Biology, University of Salzburg, 5020 Salzburg, Austria, peter.goettig@sbg.ac.at
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26582203$$D View this record in MEDLINE/PubMed
BookMark eNo1UDtPwzAYtBCI0sLMhjyypNhObCdjVZUWUQTiIbFFjvO5uDhJiR2k8OsJarnldA_dcGN0XDc1IHRJyZQSmdxsCz19oJRPRUZJJo_QGSVpHMWcvo_Q2PstGZBk9BSNmOApYyQ-Q-0Mv9h64wAvXa9VjVXA4QNwlkXrptnhxuBVVw3-vXLOfrZg66gFpwKU-Al2wZbKA2b4GTbdn-vxTAf7rYJthq26xIv6p68GqfeBDf05OjHKebg48AS93S5e56to_bi8m8_WkeYkC5GhXIlCEJJxrlLCmDGiILwgShohkxRIzGKaEEiV0IXRQoHkLDFKSpkYlrAJut7v7trmqwMf8sp6Dc6pGprO51QKkvKUxmSoXh2qXVFBme9aW6m2z_9_Yr_V_WmL
CitedBy_id crossref_primary_10_1016_j_jprot_2017_05_024
crossref_primary_10_1038_s41598_018_29058_6
crossref_primary_10_3390_ijms241814035
crossref_primary_10_1016_j_semcancer_2017_03_002
crossref_primary_10_3390_toxins9080242
crossref_primary_10_1016_j_procbio_2019_08_019
crossref_primary_10_1038_s41568_021_00436_z
crossref_primary_10_3390_ijms17121969
crossref_primary_10_1002_btpr_2752
crossref_primary_10_1016_j_actatropica_2016_12_018
crossref_primary_10_1016_j_jbc_2022_102403
crossref_primary_10_1093_evolut_qpaf012
crossref_primary_10_1016_j_abb_2016_05_017
crossref_primary_10_1515_hsz_2016_0205
crossref_primary_10_1007_s00253_016_7712_4
crossref_primary_10_1515_hsz_2024_0127
crossref_primary_10_1016_j_biochi_2019_09_004
crossref_primary_10_1016_j_jbc_2021_101227
crossref_primary_10_1515_hsz_2018_0148
ContentType Journal Article
Copyright 2016 by The American Society for Biochemistry and Molecular Biology, Inc.
Copyright_xml – notice: 2016 by The American Society for Biochemistry and Molecular Biology, Inc.
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1074/jbc.M115.691097
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Anatomy & Physiology
Chemistry
EISSN 1083-351X
EndPage 604
ExternalDocumentID 26582203
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-DZ
-ET
-~X
0R~
18M
29J
2WC
34G
39C
4.4
53G
5BI
5GY
5RE
5VS
79B
85S
AAEDW
AAFWJ
AALRI
AARDX
AAXUO
ABDNZ
ABOCM
ABPPZ
ABRJW
ACGFO
ACNCT
ADBBV
ADIYS
ADNWM
ADVLN
AENEX
AEXQZ
AFOSN
AFPKN
AITUG
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
AOIJS
BAWUL
BTFSW
CGR
CJ0
CS3
CUY
CVF
DIK
DU5
E3Z
EBS
ECM
EIF
EJD
F5P
FDB
FRP
GROUPED_DOAJ
GX1
H13
HH5
HYE
IH2
KQ8
L7B
N9A
NPM
OK1
P0W
P2P
R.V
RHF
RHI
RNS
ROL
RPM
SJN
TBC
TN5
TR2
UHB
UKR
UPT
VQA
W8F
WH7
WOQ
XSW
YQT
YSK
YWH
YZZ
Z5M
~02
~KM
.7T
7X8
AAYWO
ACVFH
ADCNI
AEUPX
AFPUW
AIGII
AKBMS
AKYEP
ID FETCH-LOGICAL-c509t-f15a6b600955a8022ff6b05b0a7f6748e0323140e8a6cbfc6ae7524fa7774f242
IEDL.DBID 7X8
ISICitedReferencesCount 22
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000367830500008&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
IngestDate Fri Sep 05 06:14:50 EDT 2025
Wed Feb 19 02:29:42 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords prostate cancer
kallikrein
zymogen activation
substrate specificity
N-linked glycosylation
serine protease
autolytic inactivation
enzyme kinetics
Language English
License 2016 by The American Society for Biochemistry and Molecular Biology, Inc.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c509t-f15a6b600955a8022ff6b05b0a7f6748e0323140e8a6cbfc6ae7524fa7774f242
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink http://www.jbc.org/article/S0021925820361937/pdf
PMID 26582203
PQID 1760858130
PQPubID 23479
PageCount 12
ParticipantIDs proquest_miscellaneous_1760858130
pubmed_primary_26582203
PublicationCentury 2000
PublicationDate 2016-01-08
PublicationDateYYYYMMDD 2016-01-08
PublicationDate_xml – month: 01
  year: 2016
  text: 2016-01-08
  day: 08
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle The Journal of biological chemistry
PublicationTitleAlternate J Biol Chem
PublicationYear 2016
SSID ssj0000491
Score 2.3062868
Snippet Human kallikrein-related peptidase 2 (KLK2) is a key serine protease in semen liquefaction and prostate cancer together with KLK3/prostate-specific antigen. In...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 593
SubjectTerms Amino Acid Sequence
Autolysis
Enzyme Activation
Fibronectins - metabolism
Glycosylation
Humans
Kinetics
Models, Molecular
Molecular Sequence Data
Polysaccharides - metabolism
Protein Structure, Secondary
Proteolysis
Recombinant Proteins - isolation & purification
Structure-Activity Relationship
Substrate Specificity
Time Factors
Tissue Kallikreins - chemistry
Tissue Kallikreins - metabolism
Title A Single Glycan at the 99-Loop of Human Kallikrein-related Peptidase 2 Regulates Activation and Enzymatic Activity
URI https://www.ncbi.nlm.nih.gov/pubmed/26582203
https://www.proquest.com/docview/1760858130
Volume 291
WOSCitedRecordID wos000367830500008&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpZ1LS8NAEMcXtYJefNVHfTGCeFvNY7NJTlKKVbAtxQf0Vjb7gGpNaluF-umdbBI8CYKXXJJAmOzO_HZ2dv6EnJtYRJFyGZVe5FDmyZgmQnMqfHycCT9kynbX74S9XjQYxP0y4TYryyorn2gdtcpkniO_ckOOdBChy72evNNcNSrfXS0lNJZJzUeUyUu6wsFPt3CkX7dq5xOyq5dEXnaRgC557NouT78xpY0t7c3_ftUW2SipEprFMNgmSzrdIfVmiivqtwVcgK3ztAn0HbLWqjTe6mTahEeMXWMNt-MFGhnEHJAIIY5pJ8smkBmwWX64F-Px6HWqRym1p1-0gn5eD6MwCIIHD4WivZ5BU1Z6aSBSBTfp18I2hS1uIPLvkuf2zVPrjpYqDFQiTMypcQPBE2571Yn8YK4xPHGCxBGhyZVKtOMjIzJHR4LLxEgudBh4zIgQydIgAeyRlTRL9QEBXJoFPFGeQsZgAl1B4BgMnUogJCQskA1yVll5iIbIty5EqrOP2fDHzg2yX_yq4aRoxzH0EKI8z_EP__D2EVlH4ilyKNExqRmc4_qErMrP-Wg2PbXDB6-9fvcbMzTQgg
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+Single+Glycan+at+the+99-Loop+of+Human+Kallikrein-related+Peptidase+2+Regulates+Activation+and+Enzymatic+Activity&rft.jtitle=The+Journal+of+biological+chemistry&rft.au=Guo%2C+Shihui&rft.au=Skala%2C+Wolfgang&rft.au=Magdolen%2C+Viktor&rft.au=Briza%2C+Peter&rft.date=2016-01-08&rft.eissn=1083-351X&rft.volume=291&rft.issue=2&rft.spage=593&rft.epage=604&rft_id=info:doi/10.1074%2Fjbc.M115.691097&rft.externalDBID=NO_FULL_TEXT